Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Home
Thomas Eleveld

Thomas Eleveld

Postdoc

Looijenga group

Phone 088 97 25 614

Email t.f.eleveld@prinsesmaximacentrum.nl

Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q
- aug. 2024
- Dylan, Stavish, et al
- Stem Cell Reports
Translation research on testicular germ cell tumors.
- jun. 2023
- Thomas, Eleveld, et al
- Tijdschrift voor Urologie
Safety Issues Related to Pluripotent Stem Cell-Based Therapies: Tumour Risk
- jan. 2023
- Sanne, Hillenius, et al
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
- jan. 2023
- Thomas F, Eleveld, et al
- Frontiers in Oncology
Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma
- sep. 2022
- Kaylee M., Keller, et al
- Frontiers in Oncology

View all publications

Thomas Eleveld

Publications

Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q

Translation research on testicular germ cell tumors.

Safety Issues Related to Pluripotent Stem Cell-Based Therapies: Tumour Risk

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma